|
YAZ VENOUS THROMBOSIS LAWYER, YASMIN VENOUS THROMBOSIS LAWYER YAZ VENOUS THROMBOSIS ATTORNEY, YASMIN VENOUS THROMBOSIS ATTORNEY Dutch Doctors Warned About Yaz Back in 2002 As far back as April 2002 the British Medical Journal (BMJ) published an article titled “Dutch GPs Warned Against New Contraceptive Pill” (BMJ 2002; 324:869.1) The article reports how Dutch General Practitioners were advised by their own professional organization not to prescribe the new low dose, monophasic oral contraceptive marketed under the name Yasmin, until studies established whether it is as safe as other contraceptive pills. The article outlines how the new contraceptive is a combination of drospirenone and ethinylestradiol and was made available in several European countries since 2000. It was approved by the FDA in the United States in May, 2001. Licensing for use in the United Kingdom took place in 2002 as well. The article outlines the story of a 17 year old Dutch girl who was on Yasmin and died of a venous thrombosis. We summarize this article here as it reflects concerns about this medication going back to the early time of its first use and marketing. The article states, “Although no direct link with Yasmin has been shown, 40 cases of venous thrombosis among women taking Yasmin, two of which were fatal, have now been reported in Europe.” [article published 4/13/02] Yasmin is manufactured in Europe by the German pharmaceutical company Schering. The article quotes a senior medical adviser to Shering, “Dr. Egbert Klaassen, said the company had conducted all the necessary research acceptable to the Medicines Evaluation Agency and the FDA. Interim results from Schering’s post-marketing surveillance study of a million cycles show that, after one year, one venous thrombosis occurred among Yasmin users, compared with five among users of other oral contraceptives.” Schering went further in its bold defense of the medication, stating that Schering is “absolutely convinced of the safety of Yasmin.” Shering wrote to all Dutch General Practitioners, Gynaecologists, and pharmacists, as noted in the above referenced article, that the 40 reported cases of venous thrombosis at the time [04/2002], among a million users of Yasmin mostly in Europe, do “absolutely not indicate an increased risk of venous thrombosis.” The article discussed here forms just one part of the various evidence from around the world about Yaz, Yasmin, Ocella, and related drugs connection to venous thrombosis and related medical tragedies for women who have taken these drugs. If you or a loved one have taken Yaz, Yasmin, or Ocella or a related drug and suffered a venous thrombosis or other serious side effect the lawyers of The Mulligan Law Firm would like to talk with you. Please contact us today at 888 446 8087. We have intake staff ready to answer your questions and mail you a free information packet and questionnaire. Yaz, Yasmin, Ocella, and related drugs have been reportedly linked with venous thrombosis, DVT, stroke, heart attack, gallbladder removal and/or disease, death, and blood clots. We are actively investigating claims by women who have taken these drugs and suffered various serious side effects. We can evaluate claims originating in all 50 United States. Act quickly as failure to investigate your legal rights and delay may cause you to lose your potential claim if it is barred by the statute of limitations that applies to your potential claim.
|
